Invention Grant
- Patent Title: IL-1 receptor accessory protein-inhibiting antibodies and antigen-binding fragments thereof
-
Application No.: US18507579Application Date: 2023-11-13
-
Publication No.: US12043669B2Publication Date: 2024-07-23
- Inventor: Birgitte Ursø , Waseem Sajid , Paola Lovato , Heidi Westh Bagger , Christoph Erkel , Petra Nussbaumer , Simon Schuster
- Applicant: LEO Pharma A/S
- Applicant Address: DK Ballerup
- Assignee: LEO Pharma A/S
- Current Assignee: LEO Pharma A/S
- Current Assignee Address: DK Ballerup
- Agency: FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP
- Priority: EP 175216 2021.05.21 EP 192805 2021.08.24
- The original application number of the division: US17664349 2022.05.20
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00
Abstract:
The present disclosure provides novel antibodies and fragments thereof targeting IL-1RAcP (Interleukin-1 receptor accessory protein). Use of IL-1RAcP inhibitors are also provided herein.
Public/Granted literature
- US20240190977A1 IL-1 Receptor Accessory Protein Inhibitors and Uses Thereof Public/Granted day:2024-06-13
Information query
